Effectiveness and cost-effectiveness of a patient-initiated botulinum toxin treatment model for blepharospasm and hemifacial spasm compared to standard care: study protocol for a randomised controlled trial
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Newman, Stanton P.
Hirani, Shashivadan P.
Ezra, Daniel G.
Funding for this research was provided by:
Merz Pharma UK
NIHR Biomedical Research Centre